Eumovate Cream clobetasone butyrate

Similar documents
Eumovate Ointment clobetasone butyrate

Dermovate Ointment clobetasol propionate

Package Leaflet: Information for the User

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Dermovate Scalp Application clobetasol propionate

Dermovate Scalp Application clobetasol propionate

Dermovate Ointment clobetasol propionate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Daktacort 2% / 1% w/w cream

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

EUMOVATE Clobetasone butyrate 0.05% w/w cream

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

PATIENT INFORMATION LEAFLET. Timodine Cream

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Retin-A 0.05% w/w cream

DP Fusidic Acid Cream

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Hair Loss Treatment Regular Strength (Minoxidil)

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Occlusal 26%w/w cutaneous solution salicylic acid

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

SIGMACORT cream and ointment

O N C E A DAY. In this leaflet FOR WOMEN

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

1 What Gyno-Daktarin cream is and what it is used for

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

ISOTREX GEL Isotretinoin 0.05% w/w

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Dalacin V Cream Clindamycin phosphate

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

CONSUMER MEDICINE INFORMATION

ACETOCAUSTIN 0,5 ml, Cutaneous solution

Daivobet 50/500 gel Dye-vo-bet

WOMEN'S Regaine EXTRA STRENGTH

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Patient Information Leaflet. Dermal Filler

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

Care of your skin. Introduction. What can you do to help? Step 1 - Hygiene. Patient Information

v MM 130.2MM FOR WOME N O N C E A D AY

A guide for patients who have been prescribed Stelara

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

Wound care and treatment Burns (1st, 2nd and 3rd degree burns) Sunburn

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Information PROPECIA Finasteride 1mg Tablet

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

EMOLLIENTS. NEW 500g NEW. pump. Up to 37% Wider choice, greater savings! cost savings. without compromising on quality or patient care!

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

HAND DERMATITIS - HOW TO CARE FOR YOUR HANDS

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

Ego DermAid 1% cream Hydrocortisone 1 % w/w

Atopic Dermatitis (Eczema) Allergy and Immunology Awareness Program

Skin Reactions from Radiation Treatments

PUVA (Psoralen + ultra violet light - wavelength A)

You and your scalp. Helpful hints and advice on treating Dry Scaly Scalp Conditions

PUVA (Psoralen + ultra violet light - wavelength A)

Administering ORENCIA (abatacept): Your Step-by-Step Guide

100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!

Hand and foot PUVA (Psoralen + ultra violet light - wavelength A)

Psoralen Tablets (Methoxypsoralen)

Dermal Fillers Information Guide

Skin Care During Radiation Therapy

Instructions For Use

BENZYL BENZOATE (benz-el benz-o-ate) Common brands include: Ascabiol, Benzemul. CROTAMITON (crow-ta-mi-ton) Common brands include: Eurax

Standard Operating Procedure for Administering creams and ointments in care homes within NHS Sutton CCG

Community Infection Prevention and Control Guidance for Health and Social Care

NHS. Blackpool Teaching Hospitals. NHS Foundation Trust. Blepharitis. Patient Information Leaflet. Ophthalmic Day Surgical Unit

Transcription:

Package leaflet: Information for the user Eumovate Cream clobetasone butyrate Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1 What Eumovate is and what it is used for 2 What you need to know before you use Eumovate 3 How to use Eumovate 4 Possible side effects 5 How to store Eumovate 6 Contents of the pack and other information 1. What Eumovate is and what it is used for Eumovate contains a medicine called clobetasone butyrate. It belongs to a group of medicines called steroids. It helps to reduce swelling and irritation. Eumovate is used to: help reduce the redness and itchiness of certain skin problems. It is used for mild skin problems or to keep your skin problem under control. These skin problems include eczema, dermatitis, nappy rash or insect bites. help reduce inflammation of the outer ear. 2. What you need to know before you use Eumovate Do not use Eumovate: if you are allergic to clobetasone butyrate or any of the other ingredients of this medicine (listed in section 6) to treat any of the following skin problems, it could make them worse: - infected skin (unless the infection is being treated with an anti-infective medicine at the same time) - acne - severe flushing of skin on and around your nose (rosacea) - itchy skin which is not inflamed Do not use if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before using Eumovate.

Warning and precautions Talk to your doctor or pharmacist before using Eumovate if: you have previously had an allergic reaction with another steroid using for a chronic leg ulcer as you may be at increased risk of local allergic reaction or infection you have been advised by your doctor to use this medicine under an occlusive dressing (including a child s nappy). Make sure that the skin is cleansed before a fresh dressing is applied to prevent infections. Occlusive dressings (including a child s nappy) make it easier for the active ingredient to pass through the skin, making it possible to accidentally use too much. you are applying to thin skin such as the face, as skin is thinner and may absorb larger amounts. Dressings or bandages should not be used on the face where the cream is applied. you are applying to the face over a long period of time as it may cause skin thinning. you have psoriasis, your doctor will want to see you more often. you are applying the cream on broken skin or within the skin folds. you are applying near eyes or on eyelids, as cataracts or glaucoma may result if the cream repeatedly enters the eye. you accidentally swallow a large amount of Eumovate, rinse the mouth out with plenty of water and contact a doctor or pharmacist for advice immediately. if an infection develops (see section 4, Possible side effects) Contact your doctor if you experience blurred vision or other visual disturbances. Children Treatment in children under 12 years of age should not normally exceed 7 days. Prolonged daily treatment in children can affect their growth. Continuous daily treatment for longer than 4 weeks is not recommended. If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine. Other medicines and Eumovate Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine, especially if you are taking ritonavir and itraconazole medications. Pregnancy, breast-feeding and fertility If you are pregnant, or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Eumovate Cream contains chloroscresol and cetostearyl alcohol Eumovate cream contains chlorocresol which may cause allergic reactions and cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis). 3. How to use Eumovate Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Using this medicine You usually apply Eumovate up to 2 times a day. This may be reduced as your skin begins to get better. This cream is for use on your skin only. Do not use on large areas of the body for a long time (such as every day for many weeks or months) - unless your doctor tells you to. If you are using an emollient (moisturising) preparation allow time for Eumovate to be absorbed after each application before applying the emollient. If you are applying the cream on someone else make sure you wash your hands after use or wear disposable plastic gloves. If your skin problem does not improve after 4 weeks talk to your doctor. Guidance on how to apply the cream 1 Wash your hands. 2 Apply a thin layer to the affected area(s) and gently rub into the skin until it has all disappeared. You can measure how much Eumovate to use with your fingertip. For children you will need to use less cream but still use an adult finger to measure out the fingertip unit. This picture shows one fingertip unit. 3 Unless you are meant to apply the cream to your hands as a part of the treatment, wash them again after using the cream. For an adult Do not worry if you find you need a little more or less than this. It is only a rough guide.

For a child Number of fingertip units needed Child s age Face and neck Arm and hand Leg and foot Front Back including buttocks 3-6 months 1 1 1 ½ 1 1 ½ 1-2 years 1 ½ 1 ½ 2 2 3 3-5 years 1 ½ 2 3 3 3 ½ 6-10 years 2 2 ½ 4 ½ 3 ½ 5 Do not use on children younger than 12 years unless advised by a doctor. If the condition worsens or does not improve within 7 days, consult a doctor. Once the condition improves, reduce both the amount applied and the frequency of application to the minimum necessary to relieve symptoms. Do not use every day for more than 4 weeks at a time. If you apply Eumovate to your face You should only apply the cream to your face if your doctor tells you to. The cream should not be used for too long as the skin on your face thins easily. Do not let the cream get into your eyes. If you use more Eumovate than you should If you apply a lot or if a lot is accidentally swallowed, it could make you ill. Talk to your doctor or go to hospital as soon as possible. If you forget to use Eumovate If you forget to apply your cream, apply it as soon as you remember. If it is close to the time you are next meant to apply it, wait until this time. If you stop using Eumovate If you use Eumovate regularly make sure you talk to your doctor before you stop using it as your condition may get worse if stopped suddenly. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop using Eumovate and tell your doctor immediately if: you find that your skin condition gets worse, you develop a generalised rash or your skin becomes swollen during treatment. You may be allergic to the cream, have an infection or need other treatment. you have psoriasis and get raised bumps with pus under the skin. This can happen during or after treatment and is known as pustular psoriasis. Other side effects you may notice when using Eumovate include: Very rare: may affect up to 1 in 10,000 people an increased risk of skin infection. an allergic skin reaction where the cream is applied. a feeling of burning, irritation or itching where the cream is applied. rash, itchy bumpy skin or redness of the skin. increased hair growth and changes in skin colour thinning of your skin and it may also damage more easily weight gain, rounding of the face delayed weight gain or slowing of growth in children bones can become thin, weak and break easily cloudy lens in the eye (cataract) or increased pressure in eye (glaucoma) increased blood sugar levels or sugar in the urine high blood pressure Not Known: frequency cannot be estimated from the available data blurred vision Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Eumovate Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the tube or carton after (EXP). The expiry date refers to the last day of that month. Do not store above 25 C. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information What Eumovate contains The active ingredient is clobetasone butyrate. Each 1 g contains 0.5 mg of clobetasone butyrate (0.05% w/w). The other ingredients are glycerol, glycerol monostearate, cetostearyl alcohol, beeswax substitute 6621, Arlacel 165, dimeticone 20, chlorocresol, sodium citrate, citric acid monohydrate and purified water. What Eumovate looks like and contents of the pack Within each carton is a tube with a plastic screw cap, which contains either 30 g or 100 g of cream. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Glaxo Wellcome UK Ltd, Stockley Park West, Uxbridge, Middlesex UB11 1BT Manufacturer Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, Durham DL12 8DT More Information If you have any questions or are not sure about anything, ask your doctor or pharmacist who will advise you. You may be able to find out more information from books in public libraries. Other formats To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK Only) Please be ready to give the following information: Product name Eumovate Cream Reference number 10949/0035 This is a service provided by the Royal National Institute of Blind People. This leaflet was last revised in September 2017. Trade marks are owned by or licensed to the GSK group of companies. 2017 GSK group of companies or its licensor